Literature DB >> 19870213

NEUTRALIZING ANTIBODIES IN ABORTIVE POLIOMYELITIS.

J D Trask1, J R Paul.   

Abstract

The neutralizing antibody content for poliomyelitis virus has been tested with both a human and a passage strain of the virus in serial samples of sera from five mild cases of abortive poliomyelitis, and an increase in this antibody content has been demonstrated in convalescent samples obtained within 4 weeks of the acute illness.

Entities:  

Year:  1933        PMID： 19870213      PMCID： PMC2132318          DOI： 10.1084/jem.58.5.531

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  2 in total

1.  A COMPARATIVE STUDY OF RECENTLY ISOLATED HUMAN STRAINS AND A PASSAGE STRAIN OF POLIOMYELITIS VIRUS.

Authors:  J R Paul; J D Trask
Journal:  J Exp Med       Date:  1933-10-31       Impact factor: 14.307

2.  THE DETECTION OF POLIOMYELITIS VIRUS IN SO CALLED ABORTIVE TYPES OF THE DISEASE.

Authors:  J R Paul; J D Trask
Journal:  J Exp Med       Date:  1932-08-31       Impact factor: 14.307
  2 in total
  5 in total

1.  VIRUSES OF POLIOMYELITIS : AN IMMUNOLOGICAL COMPARISON OF SIX STRAINS.

Authors:  J D Trask; J R Paul; A R Beebe; W J German
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

2.  Relationship between serum antibodies and subclinical infections with poliomyelitis virus.

Authors:  G C BROWN; J D AINSLIE
Journal:  J Exp Med       Date:  1951-03       Impact factor: 14.307

3.  Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.

Authors:  A J STEIGMAN; A B SABIN
Journal:  J Exp Med       Date:  1949-10       Impact factor: 14.307

4.  A COMPARATIVE STUDY OF RECENTLY ISOLATED HUMAN STRAINS AND A PASSAGE STRAIN OF POLIOMYELITIS VIRUS.

Authors:  J R Paul; J D Trask
Journal:  J Exp Med       Date:  1933-10-31       Impact factor: 14.307

5.  AN INVESTIGATION INTO THE SIGNIFICANCE OF HORMONAL FACTORS IN EXPERIMENTAL POLIOMYELITIS.

Authors:  C W Jungeblut; E T Engle
Journal:  J Exp Med       Date:  1934-01-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.